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Abstract 1 
It is now generally accepted that complex mental disorders are 2 
the results of interplay between genetic and environmental 3 
factors. This holds out the prospect that by studying GxE 4 
interplay we can explain individual variation in vulnerability 5 
and resilience to environmental hazards in the development of 6 
mental disorders. Furthermore studying GxE findings may give 7 
insights in neurobiological mechanisms of psychiatric disorder 8 
and so improve individualized treatment and potentially 9 
prevention. In this paper we provide an overview of the state of 10 
field with regard to GxE in mental disorders. Strategies for GxE 11 
research are introduced. GxE findings from selected mental 12 
disorders with onset in childhood or adolescence are reviewed 13 
(such as depressive disorders, attention-deficit/hyperactivity 14 
disorder [ADHD], obesity, schizophrenia and substance use 15 
disorders). Early seminal studies provided evidence for GxE in 16 
the pathogenesis of depression implicating 5-HTTLPR, and 17 
conduct problems implicating MAOA. Since then GxE effects 18 
have been seen across a wide range of mental disorders (e.g., 19 
ADHD, anxiety, schizophrenia, substance abuse disorder) 20 
implicating a wide range of measured genes and measured 21 
environments (e.g., pre-, peri- and postnatal influences of both a 22 
physical and a social nature). To date few of these GxE effects 23 
have been sufficiently replicated. Indeed meta-analyses have 24 
raised doubts about the robustness of even the most well studied 25 
findings. In future we need larger, sufficiently powered studies 26 
that include a detailed and sophisticated characterisation of both 27 
phenotype and the environmental risk.  28 
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Introduction 1 
Recent progress in the development of powerful new techniques 2 
for locating and identifying human susceptibility genes and 3 
genetic variations contributing to common diseases has created 4 
new opportunities to advance our understanding of the etiology 5 
of mental disorders. Two approaches, linkage and association 6 
analyses, have been applied to identify and study genetic effects 7 
across a number of mental disorders. These disorders include 8 
attention-deficit/hyperactivity disorder (ADHD), autism 9 
spectrum disorders, mood disorders, substance use disorders, 10 
schizophrenia, eating disorders, obesity, and anxiety disorders. 11 
However, despite initial optimism, few susceptibility genes (i.e. 12 
predisposing sequence variations) have been replicated with 13 
some consistency. Even for replicated findings the effects are 14 
very small: Taking all risk genotypes into account explains only 15 
a small fraction of the variation in the expression of a disorder.  16 
There are several possible explanations for this. One is that 17 
gene-environment interactions (GxE) have so far been largely 18 
ignored in the design and analyses of genetic studies. This has 19 
hampered the detection of significant genetic effects operating 20 
in those exposed to one environment and not another [69]. This 21 
notion is supported by the growing body of evidence for the 22 
contribution of genetic effects in explaining individual 23 
variability in response to all kinds of environmental hazards 24 
[68, 82, 83]. Because of this type of work it is nowadays 25 
generally accepted that complex mental disorders require an 26 
understanding of the interplay between genetic and 27 
environmental factors. This GxE hypothesis is 28 
neurobiologically plausible and is supported by a growing body 29 
of evidence (e.g., there are formal genetic studies in its favour 30 
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[51]). However, some researchers remain skeptical and call for 1 
more robust replication of initial results [70]. Clearly much 2 
more work is needed to establish (i) the conditions under which 3 
GxE occur; and (ii) the mechanisms that drive the GxE effects. 4 
Why do some genetic variants have effects only in the presence 5 
of a particular environmental exposure and/or vice versa [64]. 6 
The article starts with an overview of the impact as well as the 7 
limitations of GxE studies in general, This is followed by more 8 
detailed information about GxE research findings in some 9 
selected mental disorders with onset in childhood or 10 
adolescence. 11 
 12 
The Importance of Gene-Environment Interplay in the 13 
Etiology of Mental Disorders 14 
GxE provides a potential explanation of the individual 15 
differences in responses to environmental influences. GxE 16 
occurs when the effect of exposure to an environmental 17 
pathogen on a person’s health is conditional on the genotype 18 
[19]. For example, children exposed to an environment stressor 19 
known to increase risk for a certain psychiatric disorder (e.g., 20 
high family adversity) are at a higher risk for that disorder if 21 
they carry particular gene variants which renders them more 22 
susceptible to that stressor (see figure 1). 23 
--please add figure 1 about here-- 24 
Alternatively children carrying a genotype known to increase 25 
susceptibility for a specific mental disorder may only develop 26 
that disorder if they are exposed to specific environmental risk 27 
factors (see figure 2). 28 
--please add figure 2 about here--- 29 
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According to these models on the one hand, differences in 1 
individual genetic make-up are responsible for the differences 2 
between individuals with regard to resilience or vulnerability to 3 
the similar environmental pathogens. On the other hand, 4 
outcomes among individuals who do not vary in terms of the 5 
susceptibility allele may be determined as a function of 6 
variability in environmental exposure. In other words, GxE 7 
effects index a genetically determined liability to specific 8 
environmental influences. One example with one dichotomous 9 
genotype (present or absent) of a causative genetic mutation and 10 
one dichotomous environmental exposure (exposure versus 11 
non-exposure) is phenylketonuria (PKU) [46]. The development 12 
of PKU needs both homozygote mutations in the causative gene 13 
encoding phenylalanine hydroxylase, and exposure to 14 
phenylalanine [53]. An example for a complex genetic disorder 15 
is the alcohol flush reaction after alcohol ingestion in 16 
individuals with a genetic variant leading to lowered activity of 17 
the aldehyde dehydrogenase (ALDH), a variant which is mainly 18 
observed in the Asian population [102]. Carriers of this variant 19 
also can develop alcohol dependence after exposure to alcohol, 20 
but they are at a much lower risk to do so as compared to those 21 
who do not carry this variant. GxE processes will necessarily be 22 
more complex if several gene variants and types of 23 
environmental exposure contribute to susceptibility for a 24 
disease [46], as is almost certainly the case for mental disorders.  25 
The frequent failures to replicate initial genetic findings of 26 
association between genotypes and disease might be, among 27 
other factors (such as differences in gender ratio, ethnicity, age 28 
or comorbid conditions), caused by ignoring simple differences 29 
with respect to exposure to relevant environmental factors. If, 30 
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for example, association has been found in a sample with 1 
frequently exposed subjects but not in those infrequently 2 
exposed, and exposure has not ascertained, the source of non-3 
replication will remain elusive [69]. GxE studies thus might 4 
shed light into the genetically mediated effects underlying both 5 
resilience and vulnerability. This might help us to understand 6 
and resolve the inconsistency in results found in classical 7 
association studies with regard to correlations between 8 
disorders and genotypes. GxE findings may also provide helpful 9 
insights into the causal processes in pathogen-to-disorder 10 
pathways and therefore shed light on the underlying mechanism 11 
of “how an environmental factor external to the person gets 12 
under the skin” to result in a mental disorder [69]. As these 13 
pathways will vary between disorders, genes have the potential 14 
to offer valuable clues to these disorder-specific causal 15 
mechanisms [69]. Understanding GxE mechanisms may also 16 
provide useful hints with regard to prevention of, and 17 
intervention for, mental disorders. New findings in GxE may 18 
advance the development of individual therapeutic strategies 19 
and lead to pharmacogenetic-based therapeutic innovation [91, 20 
94]. Moffitt and co-workers [69], along with others, emphasize 21 
the importance of GxE and highlight the relevance of strategic 22 
gene-environment research. 23 
 24 
Limitations and Pitfalls in Studying GxE 25 
Despite the self-evident value of the GxE strategy there are 26 
several methodological challenges. There is the possibility of 27 
overestimating effects and false positive findings because of 28 
multiple testing and/or data dredging. Along with difficulties in 29 
statistical power [16, 63, 107], the susceptibility to artifacts in 30 
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GxE research has to be kept in mind. Statistically significant 1 
interactions are sensitive to alterations in the definition and 2 
scaling of the variables being examined: artefactual interactions 3 
can be produced by altering scaling [68]. Another problem is 4 
how to disentangle GxE from gene-environment correlations 5 
(rGE), defined as the probability of a subject’s exposure to an 6 
environmental pathogen resulting in the association of measures 7 
of environmental exposure with genetic variation [19, 87]. GxE 8 
may be affected by co-occurring rGE, in which, according to 9 
Plomin and co-workers, one can differentiate between passive, 10 
active, and evocative rGE [76]. Passive rGE occur because the 11 
parents pass on their genes and provide their rearing 12 
experiences which may be genetically influenced, e.g., parental 13 
qualities [89]. Active-evocative rGE arise because their 14 
behaviour makes people select their environments and 15 
influences other peoples’ responses to them [89]. Rutter & 16 
Silberg viewed both, GxE and rGE, as different forms of gene-17 
environment interplay [88]. Furthermore, one needs to bear in 18 
mind the role of epigenetic effects of environmental influences 19 
on gene expression or chromosomal structure and from 20 
variations in heritability according to environmental 21 
circumstances [68, 83, 87]. For more details on methodological 22 
challenges and statistical pitfalls see [28, 30, 37, 46-48, 64, 70, 23 
80, 81, 85, 108]. In order to address these and other problems 24 
Moffit and co-workers [68, 69] defined seven strategic steps for 25 
research into measured GxE (see Table 1). More detailed 26 
information pertaining to the strategies for careful deliberate 27 
GxE hypothesis testing is summarized in [19, 68, 69, 85].  28 
--please add table 1 about here-- 29 
 30 
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GxE Findings for Selected Mental Disorders with Onset in 1 
Childhood and Adolescence 2 
Initial indications – seminal studies by Caspi and Moffitt: The 3 
first molecular genetic evidence for GxE in child and adolescent 4 
psychiatric conditions comes from two classic studies by the 5 
research group of Caspi and Moffit [18, 21]. These dealt with 6 
conduct disorder, depression and emotional problems. The first 7 
study included 442 male participants and demonstrated that the 8 
effect of childhood maltreatment was moderated by a functional 9 
polymorphism in the gene encoding the neurotransmitter-10 
metabolizing enzyme monoamine oxidase A (MAOA) [18]. 11 
Carriers of the low-activity MAOA genotype who were severely 12 
maltreated more often developed conduct disorder, antisocial 13 
personality and adult violent crime than children with a high-14 
activity MAOA genotype [18]. Several researchers carried out 15 
studies to replicate this interaction [38, 42, 54, 74, 112]. Despite 16 
a number of non-replications a meta-analysis revealed an 17 
overall significant effect [54].  18 
The second key study by this group examined GxE in the 19 
pathogenesis of depression [21]. In this prospective-longitudinal 20 
study the functional polymorphism 5-HTTLPR in the promoter 21 
region of the serotonin transporter gene (SLC6A4) was found to 22 
moderate the influence of stressful experiences occurring over a 23 
5-year period before onset of depression [21]. The carriers of 24 
one or two copies of the low expressing short allele of the 5-25 
HTTLPR exhibited more depressive symptoms, diagnosable 26 
depression, and suicidality following stressful life events than 27 
individuals homozygous for the long allele [21]. Additionally, 28 
Caspi and co-workers [21] detected an interaction between 5-29 
HTTLPR and childhood maltreatment over the period between 30 
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ages 3 to 11 years. This interaction showed that childhood 1 
maltreatment predicted adult depression only among individuals 2 
carrying a short allele of the 5-HTTLPR but not among 3 
individuals homozygous for the long allele [21]. 4 
 5 
Depressive Disorders 6 
Following the striking initial findings of Caspi and co-workers 7 
[21] studies have replicated the 5-HTTLPR GxE in depression 8 
(reviewed in [108]). There have also been a number of failures 9 
to replicate [108]. A recent meta-analysis by Munafo and co-10 
workers however, concluded that the effects of 5-11 
HTTPLR x serious life events (SLE) on risk of depression are 12 
compatible with chance findings [70], and a very recent meta-13 
analysis by Risch and co-workers including published data from 14 
14 studies [22-24, 33, 39, 41, 55, 59, 65, 66, 77, 101, 103, 111] 15 
yielded no evidence for an association of the 5-HTTLPR 16 
genotype alone or in interaction with stressful life events with 17 
an elevated risk of depression [80]. In addition, a gender-18 
specific meta-analysis revealed no sex dependent interaction 19 
effects [80]. The failure of these meta-analyses to confirm the 20 
initial results of Caspi and co-workers [21] may indicate that 21 
there actually is no association. Alternatively, sample 22 
differences in background genetic and environmental factors 23 
could underlie the discrepant findings [80] (see limitations). 24 
They could also be explained by the limited comparability of 25 
replication studies due to their highly divergent samples, study 26 
designs, measures and analyses [80]. Thus, this inconsistency 27 
might be caused by methodological differences in the way of 28 
evaluating the presence of serious life events (SLE) and in 29 
different diagnostic instruments applied in depression 30 
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(structured face-to-face interviews, questionnaires or 1 
telephone/lay interviews, respectively) [29].  2 
Further genes have been investigated with regard to GxE and 3 
depression. In their case-only design, Drachmann Bukh and co-4 
workers detected an interaction between SLE and the genotypes 5 
of 5-HTTLPR and BDNF Val66Met on first episode depression 6 
[29]. Additionally, they found no 3-way interaction between 7 
SLE, 5-HTTLPR and BDNF Val66Met and no evidence for 8 
interactions between SLE and polymorphisms in COMT, TPH1, 9 
ACE, 5-HTR2A, and 5-HTR2A, respectively, on depression. 10 
According to the authors these results add evidence to the 11 
opinion that genes influence the liability to depression not only 12 
by main effects on risk but also by control of sensitivity to the 13 
pathogenic effects of the environment [29]. This is plausible as 14 
variation in the 5-HTTLPR polymorphisms may modulate the 15 
serotonergic response to stress [108]. Further evidence for this 16 
hypothesis also comes from fMRI studies which show that 17 
carriers of the short allele of 5-HTTLPR polymorphism 18 
demonstrate amygdala hyperactivity (meta-analysis see [70]) 19 
leading to increased corticol release [32]. There is also an initial 20 
indication that SLE and 5-HTTLPR polymorphism interact to 21 
predict endocrine stress reactivity in a non-clinical sample [2]. 22 
Adults homozygous for the short allele with a significant 23 
history of SLE exhibited markedly elevated cortisol secretions 24 
in response to the stressor as compared to all other groups, 25 
indicating a significant GxE on endocrine stress reactivity [2]. 26 
The authors argue that a potential moderating role of HPA-axis 27 
hyper-reactivity is a premorbid risk factor that increases the 28 
vulnerability for depression in subjects with low serotonin 29 
transporter efficiency and a history of severe life events.  30 
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In the light of the conflicting GxE results with regard to 1 
depression, very carefully designed study approaches for testing 2 
of GxE hypothesis are urgently required (see “Limitations and 3 
Pitfalls in Studying GxE”, see Table 1). Brown and Harris [17] 4 
recently outlined inconsistencies with regard to the inclusion of 5 
different kinds of environmental factors and the use of a life-6 
course perspective, respectively which may explain the failure 7 
of replication of the initial study of Caspi et al [21]. Brown and 8 
Harris hypothesized that in the context of childhood 9 
maltreatment the 5-HTTLPR polymorphism contributes to GxE 10 
via a direct link with the perpetuation of an adult onset of 11 
depression [17]. This is consistent with the hypothesis of early 12 
changes in brain function associated with the polymorphism in 13 
the context of childhood maltreatment [17].  14 
 15 
Attention-Deficit/Hyperactivity Disorder (ADHD) 16 
Molecular genetic research on ADHD has produced a number 17 
of plausible candidate genes (e.g., Dopamine D4 receptor gene 18 
(DRD4), Dopamine D5 receptor gene (DRD5), Dopamine 19 
transporter (DAT1) gene and Catechol o-methyltransferase gene 20 
(COMT). However, effects of gene variants identified through 21 
association studies are small [34], and the association findings 22 
with some markers are inconsistent across different studies (i.e., 23 
DAT1; reviewed in Banaschewski and co-workers, this issue 24 
[6]; [26]). This inconsistency may be due to the moderation of 25 
genetic effects by environmental factors that differ between 26 
samples. Thapar and co-workers emphasized that phenotypic 27 
complexity, as well as differences in the continuity and changes 28 
in clinical presentation over ADHD will both be influenced by 29 
the interplay between pre- and perinatal as well as psychosocial, 30 
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environmental and genetic risk factors [105]. The impacts of 1 
environmental factors, such as intrauterine exposure to different 2 
drugs (prenatal smoke exposure: [9, 49, 57, 71]; alcohol 3 
consumption during pregnancy: [15, 57]), psychosocial 4 
adversity [58], mothers’ expressed emotion (EE) [15, 78, 95, 5 
96], severe early deprivation [97, 99, 100], or low birth weight 6 
[57, 106], have been studied in GxE investigations. Besides 7 
highlighting the role of the environment in modulating genetic 8 
effects some of these studies provide evidence for a genetic 9 
contribution to continuity of the disorder [31, 56, 92] and the 10 
development of comorbid anti-social behaviour [57, 104, 106]. 11 
 12 
Prenatal environmental exposures: A prospective study 13 
including 161 children suggested that maternal prenatal 14 
smoking modifies the impact of the high-risk 10-repeat (10r) 15 
DAT1 allele of the 40-bp VNTR (40 base-pair variable number 16 
of tandem repeats) polymorphism in the 3’UTR of the DAT1 17 
gene [49]. Symptoms of hyperactivity, impulsivity as well as 18 
oppositional behaviour were increased among children who 19 
were homozygous for the DAT1 10r allele, but only if those 20 
children were exposed to prenatal maternal smoking [49]. 21 
However, Neuman and co-workers [71] failed to replicate this 22 
GxE between prenatal smoking exposure and the DAT1 10-23 
repeat allele in children with a diagnosis of ADHD, although 24 
the odds for a DSM IV-diagnosis of ADHD was 1.8 times 25 
greater in children whose genotype at the DAT1 3’VNTR 26 
contained the 9-repeat (9r) allele and whose mother smoked 27 
during pregnancy than for twins who had neither of these risk 28 
factors [71]. Apart from the possibility that the sample was too 29 
small this failure to replicate may be due to defining tobacco 30 
Gene-Environment Interaction 
13 
use in pregnancy as smoking more than 20 cigarettes a day. In a 1 
longitudinal study (Mannheim Study of Children at Risk) 2 
including 305 adolescents at age 15 years, Becker and co-3 
workers [9] partly confirmed the findings of Kahn and co-4 
workers [49], indicating that male homozygous DAT1-10r allele 5 
carriers with prenatal smoke exposure had significantly higher 6 
symptoms of hyperactivity-impulsivity than males from all 7 
other groups [9]. In contrast, Brookes and co-workers failed to 8 
confirm the findings of Kahn and co-workers [49] in a clinical 9 
sample [15, 57]. However, this group found evidence for an 10 
interaction of a DAT1 risk haplotype and maternal use of 11 
alcohol during pregnancy [15]. Langley and co-workers [57] 12 
failed to replicate this finding perhaps because they did not 13 
genotype both markers of the two marker haplotype of DAT1. 14 
On the whole, the reported inconsistencies in studies of GxE 15 
(e.g. for ADHD) elucidate the urgent needs of replication 16 
studies with both accurate and consistent measures of 17 
environmental factors and genetic variants, respectively, and in 18 
meta-analyses [57]. 19 
 20 
Postnatal psychosocial adversity: The Mannheim Study of Risk 21 
Children also showed that carriers of the DAT1 haplotype 22 
comprising the 6-repeat and 10-repeat alleles who grew up in 23 
greater psychosocial adversity exhibited significantly more 24 
inattention and higher hyperactivity-impulsivity than those with 25 
other genotypes/haplotypes or those living in less adverse 26 
family conditions [58]. Two recent papers provide more 27 
evidence for the potential role of the psycho-social environment 28 
in moderating genetic effects in ADHD. Building on previous 29 
work highlighting the role of mothers’ expressed emotion (EE) 30 
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as a risk factor for poor outcomes in ADHD [78], the first study 1 
[96] examined whether the effects of mothers’ EE on ADHD 2 
children, in terms of the development of conduct and emotional 3 
problems, was moderated by genetic variants in a large sub-4 
sample of the IMAGE study [15]. The results suggested that the 5 
impact of EE was moderated by the presence of specific DAT1 6 
and 5HTTLPR genotypes; children who did not have the DAT1 7 
10r/10r or the 5HTTLPR l/l genotypes showed an effect of EE 8 
on conduct problems. As far as emotional problems were 9 
concerned, EE had effects only on those who carried the DAT1 10 
9r/9r alleles. The second study [99] was carried out as part of 11 
the English and Romanian Adoptees (ERA) longitudinal study 12 
[86] of the effects of severe early deprivation on development. 13 
Previous studies highlighted a link between institutional 14 
deprivation and symptoms of ADHD [97, 100], but only in a 15 
sub-sample of cases. The results showed that the risk for 16 
symptoms of ADHD associated with early institutional 17 
deprivation was moderated by the DAT1 but not the DRD4 18 
genotypes, an effect that was first apparent in early, and 19 
persisted through mid-adolescence. In both studies it appeared 20 
that the genetic make-up altered susceptibility of children to 21 
variations in their social environment [10].  22 
So far, most GxE studies have employed a candidate gene 23 
approach. Studying environmental effects might also be a good 24 
strategy for finding potential new genetic markers using purely 25 
quantitative strategies such as QTL mapping and genome wide 26 
association studies. In the first study of this sort in ADHD, 27 
Sonuga-Barke and co-workers [95] conducted a GxE analysis in 28 
the context of a genome-wide association scan of the IMAGE 29 
study (with 429,981 SNPS available) to identify novel genes 30 
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whose effects are moderated by high maternal EE. While no 1 
GxE effect reached genome-wide significance, a number of 2 
nominal significant effects were observed (p< .105) in particular 3 
interactions for the genes SLC1A1 and NRG3 represent 4 
reasonable candidates for further investigation given their 5 
previous association with several psychiatric illnesses. 6 
 7 
Obesity 8 
Obesity is a multi-factorial trait that results from a complex 9 
interplay between genes and environment [62]. The surge in the 10 
prevalence of obesity occurred within a short period of time 11 
suggesting that environmental and behavioural lifestyle factors 12 
play a strong role [1]. GxE is gaining increased emphasis due to 13 
the large individual differences in responses to the obesogenic 14 
environment – individuals with a genetic predisposition to 15 
develop obesity will show the greatest weight gain, whereas 16 
individuals with genetic “resistance” to obesity will gain little, 17 
if any, weight [1]. Environmental factors influence behaviour or 18 
lifestyles that determine energy intake or energy expenditure 19 
[13]. The differences in individual responses to prevention and 20 
treatment strategies, including negative energy balance due to 21 
increased energy expenditure and decreased energy intake, 22 
seem also to be influenced by individuals’ genetic background 23 
[14]. 24 
There have already been numerous efforts to incorporate 25 
genetic and/or gene-environment information into obesity 26 
intervention and prevention [14]. Some genes have been 27 
reported to be associated with weight loss following 28 
intervention (e.g. lifestyle change, pharmacological/dietary 29 
interventions, and exercise) (summary [14]). For instance, one 30 
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polymorphism (rs9939609) in the fat mass and obesity 1 
associated gene (FTO) was found to have an effect on the body 2 
mass index (BMI), which was replicated in other large samples 3 
[62]. Individuals homozygous for the risk A-allele weigh on 4 
average about 3-4 kg more and have a 1.6-fold increased risk of 5 
obesity as compared to those who have not inherited a risk 6 
allele [62]. Furthermore, there is evidence for a significant FTO 7 
genotype x physical activity interaction, where the physically 8 
inactive homozygous carriers of the risk A-allele had an 9 
increase in BMI as compared to homozygous carriers of the T-10 
allele [5]. Additionally, other FTO variants showed a significant 11 
association with physical activity [79]. However, regarding 12 
these GxE with FTO variants and physical activity the findings 13 
in different studies are inconsistent. This could be explained 14 
among others by the use of different measurements of physical 15 
activity (review [4]). 16 
Additionally, animal models provide evidence for interaction of 17 
genetic background and the impact of perinatal and early 18 
childhood environments on metabolic, physiological and 19 
neuroendocrine functions and their influence on the 20 
development of obesity [61]. Furthermore, the systematic 21 
genome-wide association (GWA) study approach holds 22 
impressive prospects for the future, provided that the lifestyle 23 
factors dietary intake and physical activity are measured 24 
accurately because erroneous self-reporting of these factors is a 25 
well-known problem (review [4]). 26 
 27 
Schizophrenia  28 
The molecular genetic basis of schizophrenia has been 29 
extensively studied. The SzGene database ([3]; 30 
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http://www.szgene.org/) provides an up-to-date ranking list of all 1 
relevant candidate gene variants (to date in about 30 genes) 2 
based on meta-analyses of association studies. Although, as with 3 
most complex phenotypes, it is very likely that there may be 4 
many rare variants which contribute substantially to the disorder, 5 
effect sizes of common single variants are usually small, i.e. 6 
average summary odds ratio rarely exceed 1.2 [3]. Evidence for 7 
an association between environmental exposure and 8 
schizophrenia is most solid for paternal age, migration, obstetric 9 
complications (fetal hypoxia and proxies for folate deficiency, 10 
maternal infection, or stress during pregnancy), urbanicity, and 11 
cannabis use, the latter two particularly in case of exposure 12 
during development (see [44] and [109] for review). Findings 13 
from twin, adoption, and family studies generally suggest that a 14 
synergy between genetic and environmental factors determines 15 
psychotic symptoms and disorder, particularly for exposure to 16 
migration, urbanicity, obstetric complications, cannabis, stress, 17 
and developmental trauma [109] providing a broad range of 18 
potential environmental factors for GxE studies. Generally, the 19 
neurobiological mechanism driving the effects of these 20 
environmental exposures is unclear rendering the selection of 21 
potentially relevant genetic variants for GxE studies difficult.  22 
A few promising hypotheses do exist and some have been tested: 23 
A recent study [72] provided initial evidence that variants in four 24 
out of 13 tested candidate genes (AKT1, BDNF, DTNBP1 and 25 
GRM3), known to be regulated by hypoxia or involved in 26 
vascular functioning in the brain, showed nominally significant 27 
interaction with at least one serious obstetric complication event 28 
(as a proxy of fetal hypoxia) in 116 patient-trios. Another 29 
interesting hypothesis related to obstetric complication is the 30 
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potential GxE interaction between prenatal virus exposure and 1 
genes involved in the immune response e.g. genes located in the 2 
major histocompatibility complex (MHC) region [67]. A first 3 
study examining interaction of season of birth and risk variants 4 
in the MHC region, however, did not provide any evidence for 5 
GxE [98]. Yet, it is possible that prenatal environmental factors 6 
may also alter functioning and structure of relevant genes: e.g., 7 
folate, which is deficient prenatally in some individuals with 8 
schizophrenia, is necessary for normal DNA-methylation and 9 
this complicates the picture substantially. Thus, epigenetic 10 
changes during neurodevelopment have to be considered.  11 
In the study of Caspi and co-workers [20], the COMT Val158Met 12 
Val allele moderated the risk of developing schizophreniform 13 
disorder at age 26 following cannabis use in adolescence. 14 
Further, in a double-blind randomized controlled trial [45] the 15 
COMT Val allele was associated with an increased sensitivity to 16 
the negative cognitive effects of cannabis in patients with 17 
psychoses. In another study [110], the COMT Met allele 18 
increased the effect of stress on psychotic and affective 19 
experiences in daily life in 31 patients with psychosis and 20 
cannabis use, but not in non-psychotic cannabis users. There is 21 
evidence, derived from animal models (review [44]), suggesting 22 
that there are other promising genes (i.e. neuregulin 1 and the 23 
genes regulating the dopaminergic and the GABA system) which 24 
potentially moderate the effect of cannabis on the risk of 25 
schizophrenia. Furthermore, variation in Neuregulin 1 was also 26 
reported to moderate the effect of high expressed emotion on the 27 
level of unusual thoughts in 200 patients with schizophrenia 28 
[52]. 29 
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In conclusion, relatively few GxE interaction studies in 1 
schizophrenia are published to date. Promising testable 2 
hypotheses based on epidemiological and experimental 3 
neurobiological findings are available and need to be examined.  4 
 5 
Substance Use Disorders  6 
Substance use disorders (SUD) are common, multi-factorial 7 
disorders, which constitute the leading cause of a wide variety 8 
of morbidity and mortality conditions. Both genetic and 9 
environmental factors have been implicated in their 10 
development, with heritability estimates ranging from 50 to 11 
60% [40]. Moreover, growing evidence suggests that 12 
vulnerability to SUD may result from GxE [108]. Among the 13 
brain systems involved in the physiological response to drugs of 14 
abuse, much attention has been placed on the hypothalamic-15 
pituitary-adrenocortical (HPA) axis. The link between stressful 16 
experiences and substance use has long been discussed [93], 17 
with the stress-coping model of addiction proposing that 18 
substance use serves to regulate stress-related negative affect. A 19 
critical role in the regulation of the HPA axis pertains to the 20 
corticotropin-releasing hormone (CRH) system, making the 21 
genes encoding the CRH receptors (CRHR1, CRHR2) 22 
prominent candidates for GxE studies. Blomeyer and co-23 
workers [12] provided the first evidence that genetic variation 24 
in CRHR1 moderated the impact of stress on heavy drinking in 25 
adolescents. In 15-year-olds, the number of stressful life events 26 
during the past three years was found to be significantly related 27 
to increasing rates of heavy drinking only among individuals 28 
homozygous for the C allele of the haplotype-tagging SNP 29 
rs1876831. Recently, Schmid and co-workers [90] 30 
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demonstrated that the CRHR1 gene and stressful life events 1 
interacted to predict both drinking initiation in adolescence and 2 
progression of heavy alcohol use into young adulthood. 3 
Findings from animal research support a role for GxE in the 4 
development of excessive alcohol intake. In studies with 5 
nonhuman primates, Barr and co-workers [7] revealed that the 6 
effects of early stress on alcohol use in later life were 7 
conditional on variation in the serotonin transporter gene, with 8 
higher consumption only in carriers of the S allele of 5-9 
HTTLPR. Subsequent studies in humans yielded inconsistent 10 
results. While Covault and co-workers [27] and Kaufman and 11 
co-workers [50] found earlier and heavier alcohol use only 12 
among carriers of the S allele following stressful life events, 13 
Olsson and co-workers [75] observed a decrease in binge 14 
drinking in risk settings with each additional copy of the S 15 
allele. Nilsson and co-workers [73] reported that adolescents 16 
with poor family relations had an increased risk of alcohol 17 
intoxication when carrying the heterozygous LS genotype of 5-18 
HTTLPR. Laucht and co-workers [60] demonstrated that, when 19 
exposed to high psychosocial adversity, individuals with the LL 20 
genotype exhibited more hazardous drinking.  21 
There are several potential reasons for these conflicting 22 
findings. One major reason relates to the fact that substance use 23 
and SUD represent a heterogeneous phenotype, which may be 24 
differentiated into several subgroups (e.g. Cloninger’s typology 25 
of problem drinking [25]). However, previous studies usually 26 
neglected issues of substance use typology. An additional factor 27 
that could have contributed to inconsistency may be the 28 
heterogeneity wide variety of in measures of environmental 29 
adversity used in the different studies. While in several studies 30 
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(e.g. [27]) environmental adversity was characterized by 1 
exposure to discrete acute events, others focused on chronic 2 
difficulties surveyed over a period of years ([73]). However, 3 
research on individual differences in biological reactivity to 4 
environmental stress has highlighted the duration of a stressor 5 
as an important determinant of the stress response. 6 
 7 
Conclusions and Implications 8 
There is an emerging consensus that inter-individual variability 9 
in an individuals response to environmental exposures can be 10 
explained by genetic moderation of such effects. This gene-11 
environment interplay may explain the individuals’ 12 
vulnerability and resilience to environmental hazards in the 13 
development and expression of mental disorders. In this paper 14 
we have reviewed the current state of the field with regard to 15 
GxE in a range of disorders with childhood and adolescent 16 
onset. We highlight the progress made to date – some candidate 17 
GxE processes have been identified for each disorder and in 18 
some cases these have been replicated. Nevertheless, these 19 
initial GxE findings have to be interpreted with caution. The 20 
replication of GxE findings has in general proved to be 21 
challenging - as is also the case for replication of association 22 
findings in classical candidate genetic studies. Furthermore, the 23 
variance explained by both genetic main effects and GxE 24 
effects is invariably small. Initial GxE findings have been 25 
challenged by studies using more stringent research designs 26 
which better ensure that relations with the measured 27 
environmental variables are not influenced by other correlated 28 
environmental variables or background common genetic 29 
influences [36]. Furthermore, most GxE studies have had only 30 
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small samples which may explain why GxE effects are difficult 1 
to detect and replicate [36]. Besides possible GxE in the 2 
pathogenesis of mental disorders, genetic and environmental 3 
effects on the course of a disorder during development are 4 
important to consider. Even where GxE does not contribute to 5 
the initial development of the disorder, it may have a modifying 6 
effect on the developmental course and outcome [104]. 7 
However, up to now in genetic studies not much attention was 8 
paid to the developmental course of a disorder. This is 9 
especially true for GxExAge. Thus, future studies in mental 10 
disorders should put more emphasis on GxE in the course of 11 
development (see [99]).  12 
Despite all of these caveats and limitations the study of GxE 13 
effects - although still in its infancy - offers a number of 14 
exciting possibilities across a range of different domains. It will 15 
surely stimulate progress in our understanding of the basic 16 
neuroscience on childhood onset psychiatric problems. In future 17 
genetic research, GxE studies may provide new insights into 18 
biological pathways underlying the pathophysiology of mental 19 
disorders. It will also play a crucial role in our growing 20 
comprehension/investigation of vulnerability [11] and resilience 21 
[35, 84]. Longitudinal GxE research will be especially 22 
important as it can help us to better understand heterogeneity in 23 
mental disorders. This in turn can be exploited in both the 24 
development of new therapies and the targeting of existing 25 
therapies. If we can overcome the methodological challenges 26 
that face GxE research, the new insights in biological pathways 27 
derived from the investigation of GxE might provide new ways 28 
of individualized prevention and therapeutic strategies. 29 
 30 
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Table 1: Seven strategic steps for research into measured 1 
gene-environment interaction (Table adapted, [69]) 2 
 3 
Step 1: Consulting quantitative behavioural genetic models of the disorder 
Step 2: Identifying a candidate environmental pathogen for the disorder 
Considerations for selecting environmental risks for inclusion in GxE research on 
mental disorders 
disorder develops more frequently in persons exposed to the environmental 
pathogen compared to those not exposed 
 variability in response among people exposed to the same environmental risk 
 plausible effect of the environmental risk on biological systems involved in 
the disorder 
 evidence that the putative risk is a true environmental pathogen having causal 
effects 
Step 3: Optimizing measurement of environmental risk 
Considerations for improved environmental measurement to support GxE 
research 
 proximal measures of environmental pathogens 
 age-specific environmental pathogens 
 the cumulative nature of environmental influences 
 retrospective measures of environmental pathogens 
Step 4: Systematic genome-wide approach or identifying candidate susceptible genes 
Considerations for choosing among candidate genes as they emerge 
 common polymorphic variants 
 evidence of direct gene-to-disorder association 
 functional significance in relation to reactivity to the environmental pathogen 
Step 5: Testing for an interaction 
 statistical models 
 study sampling designs. 
 ascertaining the validity of a GxE finding 
Step 6: Evaluating whether a GxE interaction extends beyond the initially 
   hypothesized triad of genes, environmental pathogen, and disorder 
Step 7: Confirmation in independent samples 
             Meta-analyses 
Validation of findings in GxE studies in experimental studies 
 animal models (for example [8]) 
 functional brain imaging studies (for example [43]) 
 Pharmacogenetics (for example [91, 94]) 
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Figure legends: 1 
 2 
Figure 1: Environmental factors only lead to a disorder in 3 
presence of a specific genetic make-up 4 
 5 
Figure 2: An individual with a susceptible genetic make-up will 6 
only develop a disorder if there are additional environmental 7 
pathogens 8 
 9 
 10 
 11 
Gene-Environment Interaction 
1 
References 1 
1. Agurs-Collins T, Bouchard C (2008) Gene-2 
nutrition and gene-physical activity interactions in 3 
the etiology of obesity. Introduction. Obesity 4 
(Silver Spring) 16 Suppl 3:S2-4 5 
2. Alexander N, Kuepper Y, Schmitz A, Osinsky R, 6 
Kozyra E, Hennig J (2009) Gene-environment 7 
interactions predict cortisol responses after acute 8 
stress: implications for the etiology of depression. 9 
Psychoneuroendocrinology 34:1294-1303 10 
3. Allen NC, Bagade S, McQueen MB, Ioannidis JP, 11 
Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L 12 
(2008) Systematic meta-analyses and field 13 
synopsis of genetic association studies in 14 
schizophrenia: the SzGene database. Nat Genet 15 
40:827-834 16 
4. Andreasen CH, Andersen G (2009) Gene-17 
environment interactions and obesity--further 18 
aspects of genomewide association studies. 19 
Nutrition 25:998-1003 20 
5. Andreasen CH, Stender-Petersen KL, Mogensen 21 
MS, Torekov SS, Wegner L, Andersen G, Nielsen 22 
AL, Albrechtsen A, Borch-Johnsen K, Rasmussen 23 
SS, Clausen JO, Sandbaek A, Lauritzen T, Hansen 24 
L, Jorgensen T, Pedersen O, Hansen T (2008) Low 25 
physical activity accentuates the effect of the FTO 26 
rs9939609 polymorphism on body fat 27 
accumulation. Diabetes 57:95-101 28 
6. Banaschewski T, Becker K, Friedel S, Franke B, 29 
Coghill D Molecular Genetics in Attention-30 
Deficit/Hyperactivity Disorders: An Overview.  31 
7. Barr CS, Newman TK, Lindell S, Shannon C, 32 
Champoux M, Lesch KP, Suomi SJ, Goldman D, 33 
Higley JD (2004) Interaction between serotonin 34 
transporter gene variation and rearing condition in 35 
alcohol preference and consumption in female 36 
primates. Arch Gen Psychiatry 61:1146-1152 37 
8. Barr CS, Newman TK, Shannon C, Parker C, 38 
Dvoskin RL, Becker ML, Schwandt M, Champoux 39 
M, Lesch KP, Goldman D, Suomi SJ, Higley JD 40 
(2004) Rearing condition and rh5-HTTLPR 41 
interact to influence limbic-hypothalamic-42 
pituitary-adrenal axis response to stress in infant 43 
macaques. Biol Psychiatry 55:733-738 44 
9. Becker K, El-Faddagh M, Schmidt MH, Esser G, 45 
Laucht M (2008) Interaction of dopamine 46 
transporter genotype with prenatal smoke exposure 47 
on ADHD symptoms. J Pediatr 152:263-269 48 
10. Belsky J, Bakermans-Kranenburg M, van 49 
Itzendoorn M (2007) For better and for worse: 50 
Differential susceptibility to environmental 51 
influences. Current Directions In Psychological 52 
Science 16:300-304 53 
11. Belsky J, Jonassaint C, Pluess M, Stanton M, 54 
Brummett B, Williams R (2009) Vulnerability 55 
Gene-Environment Interaction 
2 
genes or plasticity genes? Mol Psychiatry 14:746-1 
754 2 
12. Blomeyer D, Treutlein J, Esser G, Schmidt MH, 3 
Schumann G, Laucht M (2008) Interaction 4 
between CRHR1 gene and stressful life events 5 
predicts adolescent heavy alcohol use. Biol 6 
Psychiatry 63:146-151 7 
13. Bouchard C (2008) Gene-environment interactions 8 
in the etiology of obesity: defining the 9 
fundamentals. Obesity (Silver Spring) 16 Suppl 10 
3:S5-S10 11 
14. Bray MS (2008) Implications of gene-behavior 12 
interactions: prevention and intervention for 13 
obesity. Obesity (Silver Spring) 16 Suppl 3:S72-78 14 
15. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, 15 
Knight J, Chen CK, Huang YS, Sethna V, Taylor 16 
E, Chen W, Breen G, Asherson P (2006) A 17 
common haplotype of the dopamine transporter 18 
gene associated with attention-deficit/hyperactivity 19 
disorder and interacting with maternal use of 20 
alcohol during pregnancy. Arch Gen Psychiatry 21 
63:74-81 22 
16. Brookes ST, Whitley E, Peters TJ, Mulheran PA, 23 
Egger M, Davey Smith G (2001) Subgroup 24 
analyses in randomised controlled trials: 25 
quantifying the risks of false-positives and false-26 
negatives. Health Technol Assess 5:1-56 27 
17. Brown GW, Harris TO (2008) Depression and the 28 
serotonin transporter 5-HTTLPR polymorphism: a 29 
review and a hypothesis concerning gene-30 
environment interaction. J Affect Disord 111:1-12 31 
18. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, 32 
Craig IW, Taylor A, Poulton R (2002) Role of 33 
genotype in the cycle of violence in maltreated 34 
children. Science 297:851-854 35 
19. Caspi A, Moffitt TE (2006) Gene-environment 36 
interactions in psychiatry: joining forces with 37 
neuroscience. Nat Rev Neurosci 7:583-590 38 
20. Caspi A, Moffitt TE, Cannon M, McClay J, 39 
Murray R, Harrington H, Taylor A, Arseneault L, 40 
Williams B, Braithwaite A, Poulton R, Craig IW 41 
(2005) Moderation of the effect of adolescent-42 
onset cannabis use on adult psychosis by a 43 
functional polymorphism in the catechol-O-44 
methyltransferase gene: longitudinal evidence of a 45 
gene X environment interaction. Biol Psychiatry 46 
57:1117-1127 47 
21. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig 48 
IW, Harrington H, McClay J, Mill J, Martin J, 49 
Braithwaite A, Poulton R (2003) Influence of life 50 
stress on depression: moderation by a 51 
polymorphism in the 5-HTT gene. Science 52 
301:386-389 53 
22. Cervilla JA, Molina E, Rivera M, Torres-Gonzalez 54 
F, Bellon JA, Moreno B, Luna JD, Lorente JA, 55 
Gene-Environment Interaction 
3 
Mayoral F, King M, Nazareth I, Gutierrez B 1 
(2007) The risk for depression conferred by 2 
stressful life events is modified by variation at the 3 
serotonin transporter 5HTTLPR genotype: 4 
evidence from the Spanish PREDICT-Gene cohort. 5 
Mol Psychiatry 12:748-755 6 
23. Chipman P, Jorm AF, Prior M, Sanson A, Smart D, 7 
Tan X, Easteal S (2007) No interaction between 8 
the serotonin transporter polymorphism (5-9 
HTTLPR) and childhood adversity or recent 10 
stressful life events on symptoms of depression: 11 
results from two community surveys. Am J Med 12 
Genet B Neuropsychiatr Genet 144B:561-565 13 
24. Chorbov VM, Lobos EA, Todorov AA, Heath AC, 14 
Botteron KN, Todd RD (2007) Relationship of 5-15 
HTTLPR genotypes and depression risk in the 16 
presence of trauma in a female twin sample. Am J 17 
Med Genet B Neuropsychiatr Genet 144B:830-833 18 
25. Cloninger CR, Sigvardsson S, Gilligan SB, von 19 
Knorring AL, Reich T, Bohman M (1988) Genetic 20 
heterogeneity and the classification of alcoholism. 21 
Adv Alcohol Subst Abuse 7:3-16 22 
26. Coghill D, Banaschewski T (2009) The genetics of 23 
attention-deficit/hyperactivity disorder. Expert Rev 24 
Neurother 9:1547-1565 25 
27. Covault J, Tennen H, Armeli S, Conner TS, 26 
Herman AI, Cillessen AH, Kranzler HR (2007) 27 
Interactive effects of the serotonin transporter 5-28 
HTTLPR polymorphism and stressful life events 29 
on college student drinking and drug use. Biol 30 
Psychiatry 61:609-616 31 
28. Dempfle A, Scherag A, Hein R, Beckmann L, 32 
Chang-Claude J, Schafer H (2008) Gene-33 
environment interactions for complex traits: 34 
definitions, methodological requirements and 35 
challenges. Eur J Hum Genet 16:1164-1172 36 
29. Drachmann Bukh J, Bock C, Vinberg M, Werge T, 37 
Gether U, Vedel Kessing L (2009) Interaction 38 
between genetic polymorphisms and stressful life 39 
events in first episode depression. J Affect Disord 40 
119:107-115 41 
30. Eaves LJ (2006) Genotype x Environment 42 
interaction in psychopathology: fact or artifact? 43 
Twin Res Hum Genet 9:1-8 44 
31. El-Faddagh M, Laucht M, Maras A, Vohringer L, 45 
Schmidt MH (2004) Association of dopamine D4 46 
receptor (DRD4) gene with attention-47 
deficit/hyperactivity disorder (ADHD) in a high-48 
risk community sample: a longitudinal study from 49 
birth to 11 years of age. J Neural Transm 111:883-50 
889 51 
32. El Hage W, Powell JF, Surguladze SA (2009) 52 
Vulnerability to depression: what is the role of 53 
stress genes in gene x environment interaction? 54 
Psychol Med:1-5 55 
Gene-Environment Interaction 
4 
33. Eley TC, Sugden K, Corsico A, Gregory AM, 1 
Sham P, McGuffin P, Plomin R, Craig IW (2004) 2 
Gene-environment interaction analysis of serotonin 3 
system markers with adolescent depression. Mol 4 
Psychiatry 9:908-915 5 
34. Faraone SV, Perlis RH, Doyle AE, Smoller JW, 6 
Goralnick JJ, Holmgren MA, Sklar P (2005) 7 
Molecular genetics of attention-8 
deficit/hyperactivity disorder. Biol Psychiatry 9 
57:1313-1323 10 
35. Feder A, Nestler EJ, Charney DS (2009) 11 
Psychobiology and molecular genetics of 12 
resilience. Nat Rev Neurosci 10:446-457 13 
36. Ficks CA, Waldman ID (2009) Gene-environment 14 
interactions in attention-deficit/hyperactivity 15 
disorder. Curr Psychiatry Rep 11:387-392 16 
37. Flint J, Munafo MR (2008) Forum: Interactions 17 
between gene and environment. Curr Opin 18 
Psychiatry 21:315-317 19 
38. Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes 20 
HH, Kuhn J, Riley B (2004) Childhood adversity, 21 
monoamine oxidase a genotype, and risk for 22 
conduct disorder. Arch Gen Psychiatry 61:738-744 23 
39. Gillespie NA, Whitfield JB, Williams B, Heath 24 
AC, Martin NG (2005) The relationship between 25 
stressful life events, the serotonin transporter (5-26 
HTTLPR) genotype and major depression. Psychol 27 
Med 35:101-111 28 
40. Goldman D, Oroszi G, Ducci F (2005) The 29 
genetics of addictions: uncovering the genes. Nat 30 
Rev Genet 6:521-532 31 
41. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, 32 
Freyberger HJ, John U, Cascorbi I (2005) Mental 33 
and physical distress is modulated by a 34 
polymorphism in the 5-HT transporter gene 35 
interacting with social stressors and chronic 36 
disease burden. Mol Psychiatry 10:220-224 37 
42. Haberstick BC, Lessem JM, Hopfer CJ, Smolen A, 38 
Ehringer MA, Timberlake D, Hewitt JK (2005) 39 
Monoamine oxidase A (MAOA) and antisocial 40 
behaviors in the presence of childhood and 41 
adolescent maltreatment. Am J Med Genet B 42 
Neuropsychiatr Genet 135B:59-64 43 
43. Hariri AR, Mattay VS, Tessitore A, Kolachana B, 44 
Fera F, Goldman D, Egan MF, Weinberger DR 45 
(2002) Serotonin transporter genetic variation and 46 
the response of the human amygdala. Science 47 
297:400-403 48 
44. Henquet C, Di Forti M, Morrison P, Kuepper R, 49 
Murray RM (2008) Gene-environment interplay 50 
between cannabis and psychosis. Schizophr Bull 51 
34:1111-1121 52 
45. Henquet C, Rosa A, Krabbendam L, Papiol S, 53 
Fananas L, Drukker M, Ramaekers JG, van Os J 54 
(2006) An experimental study of catechol-o-55 
Gene-Environment Interaction 
5 
methyltransferase Val158Met moderation of delta-1 
9-tetrahydrocannabinol-induced effects on 2 
psychosis and cognition. 3 
Neuropsychopharmacology 31:2748-2757 4 
46. Hunter DJ (2005) Gene-environment interactions 5 
in human diseases. Nat Rev Genet 6:287-298 6 
47. Ioannidis JP, Ntzani EE, Trikalinos TA, 7 
Contopoulos-Ioannidis DG (2001) Replication 8 
validity of genetic association studies. Nat Genet 9 
29:306-309 10 
48. Ioannidis JP, Trikalinos TA (2007) An exploratory 11 
test for an excess of significant findings. Clin 12 
Trials 4:245-253 13 
49. Kahn RS, Khoury J, Nichols WC, Lanphear BP 14 
(2003) Role of dopamine transporter genotype and 15 
maternal prenatal smoking in childhood 16 
hyperactive-impulsive, inattentive, and 17 
oppositional behaviors. J Pediatr 143:104-110 18 
50. Kaufman J, Yang BZ, Douglas-Palumberi H, 19 
Crouse-Artus M, Lipschitz D, Krystal JH, 20 
Gelernter J (2007) Genetic and environmental 21 
predictors of early alcohol use. Biol Psychiatry 22 
61:1228-1234 23 
51. Kendler KS, Karkowski LM, Prescott CA (1999) 24 
Causal relationship between stressful life events 25 
and the onset of major depression. Am J Psychiatry 26 
156:837-841 27 
52. Keri S, Kiss I, Seres I, Kelemen O (2009) A 28 
polymorphism of the neuregulin 1 gene 29 
(SNP8NRG243177/rs6994992) affects reactivity to 30 
expressed emotion in schizophrenia. Am J Med 31 
Genet B Neuropsychiatr Genet 150B:418-420 32 
53. Khoury MJ, Adams MJ, Jr., Flanders WD (1988) 33 
An epidemiologic approach to ecogenetics. Am J 34 
Hum Genet 42:89-95 35 
54. Kim-Cohen J, Caspi A, Taylor A, Williams B, 36 
Newcombe R, Craig IW, Moffitt TE (2006) 37 
MAOA, maltreatment, and gene-environment 38 
interaction predicting children's mental health: new 39 
evidence and a meta-analysis. Mol Psychiatry 40 
11:903-913 41 
55. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, 42 
Kim YH, Yoon JS (2007) Interactions between life 43 
stressors and susceptibility genes (5-HTTLPR and 44 
BDNF) on depression in Korean elders. Biol 45 
Psychiatry 62:423-428 46 
56. Langley K, Fowler TA, Grady DL, Moyzis RK, 47 
Holmans PA, van den Bree MB, Owen MJ, 48 
O'Donovan MC, Thapar A (2009) Molecular 49 
genetic contribution to the developmental course of 50 
attention-deficit hyperactivity disorder. Eur Child 51 
Adolesc Psychiatry 18:26-32 52 
57. Langley K, Turic D, Rice F, Holmans P, van den 53 
Bree MB, Craddock N, Kent L, Owen MJ, 54 
O'Donovan MC, Thapar A (2008) Testing for gene 55 
Gene-Environment Interaction 
6 
x environment interaction effects in attention 1 
deficit hyperactivity disorder and associated 2 
antisocial behavior. Am J Med Genet B 3 
Neuropsychiatr Genet 147B:49-53 4 
58. Laucht M, Skowronek MH, Becker K, Schmidt 5 
MH, Esser G, Schulze TG, Rietschel M (2007) 6 
Interacting effects of the dopamine transporter 7 
gene and psychosocial adversity on attention-8 
deficit/hyperactivity disorder symptoms among 15-9 
year-olds from a high-risk community sample. 10 
Arch Gen Psychiatry 64:585-590 11 
59. Laucht M, Treutlein J, Blomeyer D, Buchmann 12 
AF, Schmid B, Becker K, Zimmermann US, 13 
Schmidt MH, Esser G, Rietschel M, Banaschewski 14 
T (2009) Interaction between the 5-HTTLPR 15 
serotonin transporter polymorphism and 16 
environmental adversity for mood and anxiety 17 
psychopathology: evidence from a high-risk 18 
community sample of young adults. Int J 19 
Neuropsychopharmacol:1-11 20 
60. Laucht M, Treutlein J, Schmid B, Blomeyer D, 21 
Becker K, Buchmann AF, Schmidt MH, Esser G, 22 
Jennen-Steinmetz C, Rietschel M, Zimmermann 23 
US, Banaschewski T (2009) Impact of 24 
psychosocial adversity on alcohol intake in young 25 
adults: moderation by the LL genotype of the 26 
serotonin transporter polymorphism. Biol 27 
Psychiatry 66:102-109 28 
61. Levin BE (2009) Synergy of nature and nurture in 29 
the development of childhood obesity. Int J Obes 30 
(Lond) 33 Suppl 1:S53-56 31 
62. Loos RJ, Bouchard C (2008) FTO: the first gene 32 
contributing to common forms of human obesity. 33 
Obes Rev 9:246-250 34 
63. Luan JA, Wong MY, Day NE, Wareham NJ 35 
(2001) Sample size determination for studies of 36 
gene-environment interaction. Int J Epidemiol 37 
30:1035-1040 38 
64. Manolio TA, Bailey-Wilson JE, Collins FS (2006) 39 
Genes, environment and the value of prospective 40 
cohort studies. Nat Rev Genet 7:812-820 41 
65. Middeldorp CM, Cath DC, Beem AL, Willemsen 42 
G, Boomsma DI (2008) Life events, anxious 43 
depression and personality: a prospective and 44 
genetic study. Psychol Med 38:1557-1565 45 
66. Middeldorp CM, de Geus EJ, Beem AL, 46 
Lakenberg N, Hottenga JJ, Slagboom PE, 47 
Boomsma DI (2007) Family based association 48 
analyses between the serotonin transporter gene 49 
polymorphism (5-HTTLPR) and neuroticism, 50 
anxiety and depression. Behav Genet 37:294-301 51 
67. Mittal VA, Ellman LM, Cannon TD (2008) Gene-52 
environment interaction and covariation in 53 
schizophrenia: the role of obstetric complications. 54 
Schizophr Bull 34:1083-1094 55 
Gene-Environment Interaction 
7 
68. Moffitt TE, Caspi A, Rutter M (2006) Measured 1 
Gene-Environment Interactions in 2 
Psychopathology : Concepts, Research Strategies, 3 
and Implications for Research, Intervention, and 4 
Public Understanding of Genetics. Perspect 5 
Psychol Sci 1:5-27 6 
69. Moffitt TE, Caspi A, Rutter M (2005) Strategy for 7 
investigating interactions between measured genes 8 
and measured environments. Arch Gen Psychiatry 9 
62:473-481 10 
70. Munafo MR, Durrant C, Lewis G, Flint J (2009) 11 
Gene X environment interactions at the serotonin 12 
transporter locus. Biol Psychiatry 65:211-219 13 
71. Neuman RJ, Lobos E, Reich W, Henderson CA, 14 
Sun LW, Todd RD (2007) Prenatal smoking 15 
exposure and dopaminergic genotypes interact to 16 
cause a severe ADHD subtype. Biol Psychiatry 17 
61:1320-1328 18 
72. Nicodemus KK, Marenco S, Batten AJ, 19 
Vakkalanka R, Egan MF, Straub RE, Weinberger 20 
DR (2008) Serious obstetric complications interact 21 
with hypoxia-regulated/vascular-expression genes 22 
to influence schizophrenia risk. Mol Psychiatry 23 
13:873-877 24 
73. Nilsson KW, Sjoberg RL, Damberg M, Alm PO, 25 
Ohrvik J, Leppert J, Lindstrom L, Oreland L 26 
(2005) Role of the serotonin transporter gene and 27 
family function in adolescent alcohol consumption. 28 
Alcohol Clin Exp Res 29:564-570 29 
74. Nilsson KW, Sjoberg RL, Damberg M, Leppert J, 30 
Ohrvik J, Alm PO, Lindstrom L, Oreland L (2006) 31 
Role of monoamine oxidase A genotype and 32 
psychosocial factors in male adolescent criminal 33 
activity. Biol Psychiatry 59:121-127 34 
75. Olsson CA, Byrnes GB, Lotfi-Miri M, Collins V, 35 
Williamson R, Patton C, Anney RJ (2005) 36 
Association between 5-HTTLPR genotypes and 37 
persisting patterns of anxiety and alcohol use: 38 
results from a 10-year longitudinal study of 39 
adolescent mental health. Mol Psychiatry 10:868-40 
876 41 
76. Plomin R, DeFries JC, Loehlin JC (1977) 42 
Genotype-environment interaction and correlation 43 
in the analysis of human behavior. Psychol Bull 44 
84:309-322 45 
77. Power T, Stewart R, Ancelin ML, Jaussent I, 46 
Malafosse A, Ritchie K (2008) 5-HTTLPR 47 
genotype, stressful life events and late-life 48 
depression: No evidence of interaction in a French 49 
population. Neurobiol Aging 50 
78. Psychogiou L, Daley DM, Thompson MJ, Sonuga-51 
Barke EJ (2008) Do maternal attention-52 
deficit/hyperactivity disorder symptoms exacerbate 53 
or ameliorate the negative effect of child attention-54 
Gene-Environment Interaction 
8 
deficit/hyperactivity disorder symptoms on 1 
parenting? Dev Psychopathol 20:121-137 2 
79. Rampersaud E, Mitchell BD, Pollin TI, Fu M, 3 
Shen H, O'Connell JR, Ducharme JL, Hines S, 4 
Sack P, Naglieri R, Shuldiner AR, Snitker S (2008) 5 
Physical activity and the association of common 6 
FTO gene variants with body mass index and 7 
obesity. Arch Intern Med 168:1791-1797 8 
80. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, 9 
Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR 10 
(2009) Interaction between the serotonin 11 
transporter gene (5-HTTLPR), stressful life events, 12 
and risk of depression: a meta-analysis. Jama 13 
301:2462-2471 14 
81. Rutter M (2008) Biological implications of gene-15 
environment interaction. J Abnorm Child Psychol 16 
36:969-975 17 
82. Rutter M (2003) Commentary: Nature-nurture 18 
interplay in emotional disorders. J Child Psychol 19 
Psychiatry 44:934-944 20 
83. Rutter M (2007) Gene-environment 21 
interdependence. Dev Sci 10:12-18 22 
84. Rutter M (2006) Implications of resilience 23 
concepts for scientific understanding. Ann N Y 24 
Acad Sci 1094:1-12 25 
85. Rutter M (2002) The interplay of nature, nurture, 26 
and developmental influences: the challenge ahead 27 
for mental health. Arch Gen Psychiatry 59:996-28 
1000 29 
86. Rutter M, Beckett C, Castle J, Colvert E, Kreppner 30 
JM, Metha M, Stevens SE, Sonuga-Barke EJ 31 
(2007) Effects of profound early institutional 32 
deprivation: An overwiev of findings from a UK 33 
longitudinal study of Romanian adoptees. Eur J 34 
Dev Psychol 4:332-350 35 
87. Rutter M, Moffitt TE, Caspi A (2006) Gene-36 
environment interplay and psychopathology: 37 
multiple varieties but real effects. J Child Psychol 38 
Psychiatry 47:226-261 39 
88. Rutter M, Silberg J (2002) Gene-environment 40 
interplay in relation to emotional and behavioral 41 
disturbance. Annu Rev Psychol 53:463-490 42 
89. Rutter M, Silberg J, O'Connor T, Simonoff E 43 
(1999) Genetics and child psychiatry: I Advances 44 
in quantitative and molecular genetics. J Child 45 
Psychol Psychiatry 40:3-18 46 
90. Schmid B, Blomeyer D, Treutlein J, Zimmermann 47 
US, Buchmann AF, Schmidt MH, Esser G, 48 
Rietschel M, Banaschewski T, Schumann G, 49 
Laucht M (2009) Interacting effects of CRHR1 50 
gene and stressful life events on drinking initiation 51 
and progression among 19-year-olds. Int J 52 
Neuropsychopharmacol:1-12 53 
91. Serretti A, Mandelli L, Lorenzi C, Pirovano A, 54 
Olgiati P, Colombo C, Smeraldi E (2007) 55 
Gene-Environment Interaction 
9 
Serotonin transporter gene influences the time 1 
course of improvement of "core" depressive and 2 
somatic anxiety symptoms during treatment with 3 
SSRIs for recurrent mood disorders. Psychiatry 4 
Res 149:185-193 5 
92. Shaw P, Gornick M, Lerch J, Addington A, Seal J, 6 
Greenstein D, Sharp W, Evans A, Giedd JN, 7 
Castellanos FX, Rapoport JL (2007) 8 
Polymorphisms of the dopamine D4 receptor, 9 
clinical outcome, and cortical structure in 10 
attention-deficit/hyperactivity disorder. Arch Gen 11 
Psychiatry 64:921-931 12 
93. Sinha R (2001) How does stress increase risk of 13 
drug abuse and relapse? Psychopharmacology 14 
(Berl) 158:343-359 15 
94. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, 16 
Perez J, Catalano M (1998) Polymorphism within 17 
the promoter of the serotonin transporter gene and 18 
antidepressant efficacy of fluvoxamine. Mol 19 
Psychiatry 3:508-511 20 
95. Sonuga-Barke EJ, Lasky-Su J, Neale BM, Oades 21 
R, Chen W, Franke B, Buitelaar J, Banaschewski 22 
T, Ebstein R, Gill M, Anney R, Miranda A, Mulas 23 
F, Roeyers H, Rothenberger A, Sergeant J, 24 
Steinhausen HC, Thompson M, Asherson P, 25 
Faraone SV (2008) Does parental expressed 26 
emotion moderate genetic effects in ADHD? An 27 
exploration using a genome wide association scan. 28 
Am J Med Genet B Neuropsychiatr Genet 29 
147B:1359-1368 30 
96. Sonuga-Barke EJ, Oades RD, Psychogiou L, Chen 31 
W, Franke B, Buitelaar J, Banaschewski T, Ebstein 32 
RP, Gil M, Anney R, Miranda A, Roeyers H, 33 
Rothenberger A, Sergeant J, Steinhausen HC, 34 
Thompson M, Asherson P, Faraone SV (2009) 35 
Dopamine and serotonin transporter genotypes 36 
moderate sensitivity to maternal expressed 37 
emotion: the case of conduct and emotional 38 
problems in attention deficit/hyperactivity 39 
disorder. J Child Psychol Psychiatry 50:1052-1063 40 
97. Sonuga-Barke EJ, Rubia K (2008) 41 
Inattentive/overactive children with histories of 42 
profound institutional deprivation compared with 43 
standard ADHD cases: a brief report. Child Care 44 
Health Dev 34:596-602 45 
98. Stefansson H, Ophoff RA, Steinberg S, 46 
Andreassen OA, Cichon S, Rujescu D, Werge T, 47 
Pietilainen OP, Mors O, Mortensen PB, Sigurdsson 48 
E, Gustafsson O, Nyegaard M, Tuulio-Henriksson 49 
A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, 50 
Paunio T, Borglum AD, Hartmann A, Fink-Jensen 51 
A, Nordentoft M, Hougaard D, Norgaard-Pedersen 52 
B, Bottcher Y, Olesen J, Breuer R, Moller HJ, 53 
Giegling I, Rasmussen HB, Timm S, Mattheisen 54 
M, Bitter I, Rethelyi JM, Magnusdottir BB, 55 
Gene-Environment Interaction 
10 
Sigmundsson T, Olason P, Masson G, Gulcher JR, 1 
Haraldsson M, Fossdal R, Thorgeirsson TE, 2 
Thorsteinsdottir U, Ruggeri M, Tosato S, Franke 3 
B, Strengman E, Kiemeney LA, Melle I, Djurovic 4 
S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, 5 
Bramon E, Vassos E, Fraser G, Ettinger U, 6 
Picchioni M, Walker N, Toulopoulou T, Need AC, 7 
Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor 8 
RM, Murray R, Kong A, Golimbet V, Carracedo 9 
A, Arango C, Costas J, Jonsson EG, Terenius L, 10 
Agartz I, Petursson H, Nothen MM, Rietschel M, 11 
Matthews PM, Muglia P, Peltonen L, St Clair D, 12 
Goldstein DB, Stefansson K, Collier DA (2009) 13 
Common variants conferring risk of schizophrenia. 14 
Nature 460:744-747 15 
99. Stevens SE, Kumsta R, Kreppner JM, Brookes KJ, 16 
Rutter M, Sonuga-Barke EJ (2009) Dopamine 17 
transporter gene polymorphism moderates the 18 
effects of severe deprivation on ADHD symptoms: 19 
developmental continuities in gene-environment 20 
interplay. Am J Med Genet B Neuropsychiatr 21 
Genet 150B:753-761 22 
100. Stevens SE, Sonuga-Barke EJ, Kreppner JM, 23 
Beckett C, Castle J, Colvert E, Groothues C, 24 
Hawkins A, Rutter M (2008) 25 
Inattention/overactivity following early severe 26 
institutional deprivation: presentation and 27 
associations in early adolescence. J Abnorm Child 28 
Psychol 36:385-398 29 
101. Surtees PG, Wainwright NW, Willis-Owen SA, 30 
Luben R, Day NE, Flint J (2006) Social adversity, 31 
the serotonin transporter (5-HTTLPR) 32 
polymorphism and major depressive disorder. Biol 33 
Psychiatry 59:224-229 34 
102. Takeshita T, Mao XQ, Morimoto K (1996) The 35 
contribution of polymorphism in the alcohol 36 
dehydrogenase beta subunit to alcohol sensitivity 37 
in a Japanese population. Hum Genet 97:409-413 38 
103. Taylor SE, Way BM, Welch WT, Hilmert CJ, 39 
Lehman BJ, Eisenberger NI (2006) Early family 40 
environment, current adversity, the serotonin 41 
transporter promoter polymorphism, and 42 
depressive symptomatology. Biol Psychiatry 43 
60:671-676 44 
104. Thapar A, Harold G, Rice F, Langley K, 45 
O'Donovan M (2007) The contribution of gene-46 
environment interaction to psychopathology. Dev 47 
Psychopathol 19:989-1004 48 
105. Thapar A, Langley K, Asherson P, Gill M (2007) 49 
Gene-environment interplay in attention-deficit 50 
hyperactivity disorder and the importance of a 51 
developmental perspective. Br J Psychiatry 190:1-52 
3 53 
106. Thapar A, Langley K, Fowler T, Rice F, Turic D, 54 
Whittinger N, Aggleton J, Van den Bree M, Owen 55 
Gene-Environment Interaction 
11 
M, O'Donovan M (2005) Catechol O-1 
methyltransferase gene variant and birth weight 2 
predict early-onset antisocial behavior in children 3 
with attention-deficit/hyperactivity disorder. Arch 4 
Gen Psychiatry 62:1275-1278 5 
107. Uher R (2008) Gene-environment interaction: 6 
overcoming methodological challenges. Novartis 7 
Found Symp 293:13-26; discussion 26-30, 68-70 8 
108. Uher R, McGuffin P (2008) The moderation by the 9 
serotonin transporter gene of environmental 10 
adversity in the aetiology of mental illness: review 11 
and methodological analysis. Mol Psychiatry 12 
13:131-146 13 
109. van Os J, Rutten BP, Poulton R (2008) Gene-14 
environment interactions in schizophrenia: review 15 
of epidemiological findings and future directions. 16 
Schizophr Bull 34:1066-1082 17 
110. van Winkel R, Henquet C, Rosa A, Papiol S, 18 
Fananas L, De Hert M, Peuskens J, van Os J, 19 
Myin-Germeys I (2008) Evidence that the 20 
COMT(Val158Met) polymorphism moderates 21 
sensitivity to stress in psychosis: an experience-22 
sampling study. Am J Med Genet B 23 
Neuropsychiatr Genet 147B:10-17 24 
111. Wilhelm K, Mitchell PB, Niven H, Finch A, 25 
Wedgwood L, Scimone A, Blair IP, Parker G, 26 
Schofield PR (2006) Life events, first depression 27 
onset and the serotonin transporter gene. Br J 28 
Psychiatry 188:210-215 29 
112. Young SE, Smolen A, Hewitt JK, Haberstick BC, 30 
Stallings MC, Corley RP, Crowley TJ (2006) 31 
Interaction between MAO-A genotype and 32 
maltreatment in the risk for conduct disorder: 33 
failure to confirm in adolescent patients. Am J 34 
Psychiatry 163:1019-1025 35 
 36 
 37 
 38 
